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Supplemental Figure Legends 
Supplemental Figure S1. Bright-/- MEFs maintain a more plastic genetic state, Related to 
Figure 1.  (A) Cluster analysis of KO-MEF and WT-MEF microarray data. Expression of gene 
modules upregulated in pluripotent cells (Kim et al., 2010) shows little differences between KO-
MEFs and WT-MEFs. Core, genes which regulate the pluripotent state;  PRC, Polycomb 
complexes associated with the chromatin mark H3K27me3; MYC, Myc-centered regulatory 
network in mES cells, and Bivalent, mES gene promoters with both  H3K4m3 and H3K27m3 
chromatin marks. N=1.  (B) Left, GO term analyses (Ashburner et al., 2000) of genes 
upregulated in KO-MEFs compared to WT-MEFs; the x-axis denotes p-values. Right, a heatmap 
display of microarray data of individual genes comprising the 8 most highly upregulated GO 
categories. (C) Reprogrammed clones differentiate into multiple tissues that express proteins 
representative of all three germ layers. Clones were differentiated in suspension into embryoid 
bodies, plated on glass cover slips and after 5 days were stained (red) for markers of endoderm, 
α-fetoprotein (AFP); mesoderm, smooth muscle actin (SMA); and ectoderm, βIII-tubulin (βT). 
DAPI (blue) was used for nuclear staining. (D) Bright is reduced ~75% by shRNA. qPCR 
analysis of the relative gene expression of MEFs infected either with lentiviral shRNA specific 
for Bright (shBright) or the empty vector (shEMP) as a control. N=3, biological replicas, each 
with 3 technical replicates; error bars are standard deviations. (E) Reduction of BRIGHT by 
shRNA does not induce morphological changes. Brightfield images of MEFs infected either with 
shRNA against BRIGHT (shBright) or an empty vector (shEMP) as a control; image at 10x. (F) 
Conventional 4F-reprogramming does not induce Bright expression. qPCR analysis of 
endogenous Bright following lentiviral infection of Oct4, Sox2, Klf4, and Myc (pMX-OSKM) or 
the empty vector (pMX-Emp). N=3, biological replicates; error bars are standard deviations. (G) 
Brightfield (left) and fluorescent (right) images of GFP-Oct4 expressing MEFs reprogramed in 
the presence (pMX-OSKM) or absence (pMX-OSKM+shBright) of Bright; images are at 10x  
(H) Brightfield images of stable KO-iPS clone and mES cells; image at 10x. 
Supplemental Figure S2. Reprogrammed KO clones are molecularly similar to mES cells, 
Related to Figure 2. Gene expression patterns of KO-iPS closely resembled mES cells. 
SABiosciences mouse stem cell qPCR arrays were used to assess individual and replicate clones 
of WT and KO-MEFs,  mES, WT+4F, KO-iPS, KO+4F, and KO-S. Data are shown as a 
heatmap adjusted to reflect the variation from minimum to maximum values (generated using 
software from SABiosciences) for each individual gene indicated below  
Supplemental Figure S3.Gene expression pattern of reprogrammed KO clones is highly 
similar to mES cells, Related to Figure 2. (A) Scatter plot comparisons of SABiosciences 
qPCR array data are shown for (V) KO+4F versus mES, (VI) WT+4F versus mES, (VII) KO-
MEF versus WT-MEF. Genes differentially expressed with p >0.05 indicated by red 
(upregulated) or green (downregulated) circles (see also Fig. 2C). Individual genes and relative 
expression differences composing each category are:  (I) Gabrb3, 3.72; Krt1, 4.14; Myod1, 3.97; 
CD34, -5.39; Cdh5,-13.6; Col1a1, -9.39; Flt1, -2.83; Fn1, -2.38; Hck, -2.27; Kit, -2.10; Pdx1, -
2.62; Runx2, -8.17; Sema3a, -12.52; and Sfrp2, -3.91; (II) Lefty, 2.22;  Nog, 2.03; Tat, -2.94; 
(III) CD34, 3.50; Cdh5, 11.47; Commd3, 2.10; Diap2, 3.12; Hba-x, 3.31; Hck, 3.02; Nog, 2.33; 
Dnmt3b, -2.63; FGF5, -3.66; Gbx2,-4.53; Ifitm1, -2.36; Lefty, -3.77; Lin28a, -2.08, Olig2, -21.9; 
Pax6, -2.23; (IV) Olig2, 12.64; Afp,-2.27; CD34, -3.00; CDh5, -4.63; Commd3, -2.48; Diap2, -
2.52; Hba-x -3.19; Hck, -3.85; Tat, -2.34; Tdgf1, -2.22; (V) Gabrb3, 4.2; Pecam1, 2.36; CD34, -
4.62; Cdh5, -5.49; Col1a1, -11.29; Hck, -2.89; Pdx1, -7.81; Runx2, -6.35; Sema3a, -9.08; Sfrp2, 
-3.25; Tat, -2.37; (VI) Diap2, 7.77; Gabrb3, 6.72; Pecam1, 2.94; Cdx2,-4.54; Col1a1, -5.88; 
Dnmt3b, -3.06; Fgf5, -6.17; Gbx2, -8.99; Gcm1, -2.42; Grb7, -2.94; Lin28a, -3.14; Pax6, -2.39; 
Pdx1, -2.26; Sfrp2, -2.58; Utf1, -3.58; (VII) CD34, -2.42; Eomes, -2.06; Ifitm1, -2.67.  Three 
replicates each were used for the scatter plot data in (VII). All other scatter plots were graphed 
based on data for all replicates shown in the array except the WT-4F samples. In that case, only 
the first five replicates were used to avoid skewing towards one clone and to maintain equivalent 
numbers of replicates for all comparisons. (B) Heatmap of microarray data showing that of 3392 
genes whose expression in spontaneous KO-MEF colonies (KO-iPS) and mES  differed  >2 fold 
from WT-MEFs, only ~200 genes differed between KO-iPS and mES. (C) qPCR confirmation of 
selected genes from microarrays.  Primer sequences are shown in Suppl. Methods. Key 
pluripotency (eg, Oct4, Sox2, Klf4, c-Myc, and Nanog) and early differentiation (eg, Rest, Gata6, 
Foxp2) mRNA expression is consistent with microarray data. N=3, biological replicates analyzed 
with at least three technical replicates each. (D) Graphic representation of microarray data of (C) 
indicate that early differentiation factors are comparably expressed in KO-iPS and mES but not 
in KO-MEFs.  (E) Microarray analysis of genes selectively upregulated in mES (upper panel) or 
in epiblast stem cells (EpiSC) (lower panel). Of the few genes that have been previously 
observed to be differentially expressed between mES and EpiSC, KO-iPS have an intermediate 
gene expression pattern.   
Supplemental Figure S4. Overexpression of Bright decreases endogenous Oct4, Sox2, and 
Nanog expression, Related to Figure 4. (A) Brightfield image of stable Bright overexpressing 
mES used in Fig 4D and E. Image shows ES morphology was maintained. (B) Increasing levels 
of BRIGHT down-regulate core factor proteins in p19 embryonic carcinoma cells. Cells were 
transfected with increasing amounts of a CMV promoter-driven Bright expression vector, and 
harvested two days after transfection. A representative SDS-PAGE analysis is shown. 
Quantitation using ImageQuant software (not shown) of western blots from 4 independent 
experiments indicated ~20-60% down-regulation was achieved with~2-3 -fold increases in 
BRIGHT levels; p-value < .02 for OCT4 and <.001 for SOX2. (C)  Bright overexpression 
represses Oct4 (left), Nanog (below) and Sox2 (right) promoter/enhancer-driven reporter 
expression during differentiation of mES cells.  Firefly Luciferase constructs containing regions 
indicated in Figure 3B were co-transfected into mES with Renilla controls and either Myc-Bright 
or empty vector control. Cells were grown in the absence of LIF or feeder cells to allow 
differentiation and were harvested 3 to 4 days post-transfection. Three biological replicates 
performed with three technical replicates per experiment which vector-only values were set to 1. 
Error bars are standard deviations. Asterisks denote statistical significance, p-value ≤ .1, as 
determined by student’s T-test. 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Table S1. Bright-deficient mouse embryonic fibroblasts undergo both 
enhanced conventional and spontaneous reprogramming, Related to Figure 1.   
Clone typea Efficiency of initial 
colony formationb 
Total number of 
independently 
isolated clones 
Number of stably 
reprogrammed 
clonesc 
WT+4F 0.025 56 8 
KO+4F 0.37 119 40 
KO-S 0.13 99 4 
KO-O 0.027 19 0 
KO-K 0.045 82 2 
KO-M 0.07 42 0 
KO-iPS 0.05 5 3 
 
a
KO-MEFs and WT-MEFs reprogrammed with either all four (KO+4F, WT+4F) standard factors (Oct4, 
Sox2, KLF4, and c-Myc) or in the absence of Oct4 (KO-O), Sox2 (KO-S), KLF4 (KO-K), or c-Myc (KO-
M) or formed spontaneously from KO-MEFs (KO-iPS).  
b
Average number of colonies observed at day 17 divided by number of  initial MEFs plated from 
3-5 independent experiments. Data for the KO-iPS were derived from a single experiment. 
c
Number of isolated clones defined to have undergone stable reprogramming based on survival 
for > 4 passages, expression of endogenous pluripotency markers, formation of embryoid bodies, 
and differentiation into cells expressing markers of all three germ line tissues. 
  
 
 
 
 
 
Supplemental Table S2. KO-iPS are pluripotent in vivo, Related to Figure 1. 
Cell Type No. of injections No. of teratomas Efficiency 
mES 7 3 .43 
WT+4F 2 2 1.0 
KO+4F 2 2 1.0 
KO-iPS 22 7 .32 
KO-MEFs 5 0 0.0 
 
Approximately 3.5 X 105 mES, WT+4F, KO+4F, KO-iPS or ~7 X 105 KO-MEFs were injected 
subcutaneously into the flank of NSG mice. Tumor development was monitored over 4-6 weeks, 
and tumors were harvested, fixed, sectioned and stained with hemotoxylin and eosin.  Slides 
were read by trained pathologists. Efficiency of teratoma formation was determined as the 
number of tumors divided by the number of injections performed. 
 
 
 
 
 
 
 
 
Supplemental Experimental Procedures 
Cell culture:  All cells were cultured in 5% CO2 at 37°C in media containing 100U/ml Penicillin 
G, and 100ug/ml Streptomycin Sulfate (Invitrogen).  MEFs were cultured in Dulbecco’s 
Modified Eagle Media (DMEM) supplemented with 10% fetal bovine serum (FBS).  Clones 
from Bright KO-MEFs were picked under sterile conditions. ES cells and reprogrammed clones 
were grown on STO feeder cells or wild type MEFs that were mitotically inactivated with 
Mitomycin C (10ug/ml) in Dulbecco’s Modified Eagle Media (DMEM) supplemented with 20% 
ES-grade fetal bovine serum (Hyclone), 100U/ml Penicillin G, 100ug/ml Streptomycin Sulfate, 
and 10ng/ml leukemia-inhibitory factor (LIF). 
MEF generation: Embryos from E10.5 Bright-/+ x129/B6 mice were used to generate WT and 
KO MEFs.  Embryos were removed and washed in PBS.  Brain and organs were microdissected 
out and remaining material was chopped into small pieces using a scalpel and digested in 
collagenase at 37°C for 20 minutes. MEF lines used in reprogramming experiments were derived 
using paws from E11-12 embryos. The resulting cell suspension was filtered through a 45µm cell 
strainer and plated onto cell culture plates in DMEM supplemented with 10% FBS, 100U/ml 
Penicillin G, and 100ug/ml Streptomycin Sulfate and incubated at 37°C, 5% CO2.  Genotypes 
were confirmed as previously reported (Webb et al., 2011). 
Growth curve:  Actively growing WT-MEFs and KO-MEFs (~3.5 X 105) were plated onto a 
10cm2 cell culture dish for each indicated time-point.  Cells were trypsinized and counted every 
3 days.  Media was changed every second day.  Experiments were performed a minimum of 4 
times for each cell line.  Statistics performed using Microsoft Excel.  
Senescence staining: Sub-confluent plates of WT-MEFs (<15 doublings) and KO-MEFs (>50 
doubling) were fixed on cell culture plates for 20 minutes with 2% formaldehyde, washed in 
PBS, and incubated overnight at 37°C in 5mg β-galactasidase/40mM citric acid/40mM sodium 
phosphate  pH 6.0/5mM potassium ferricyanide/5mM potassium ferrocyanide/150mM 
NaCl/3mM MgCl2 (Dimri et al., 1995)  
Immunocytochemistry (ICC): Indicated clones were plated on chamber slides or cover slips. In 
some cases, cells were grown under MEF cell culture conditions for two days and alkaline 
phosphatase presence was detected using the Vector kit (SK-5100).  For pluripotency marker 
staining, individual clones were grown under ES cell culture conditions. Fixing, 
permeabilization, and immunostaining was performed with anti-NANOG, SOX2, OCT4, and 
SSEA-1 specific antibodies and appropriate fluorescently tagged secondary antibodies as 
previously described (An et al., 2010).  
Reprogramming: Stable KO-iPS clones were derived from KO-MEFs grown to confluency 
under ES cell culture conditions, inclusive of LIF. Individual colonies were picked from plates, 
briefly trypsinized (5% trypsin/1% EDTA) and replated on mitotically inactive, WT-MEF feeder 
cell lines in ES media. For standard reprogramming, lentiviruses were generated from 293T cells 
transfected using LipoD293 (SignaGen) with the Tet-inducible plasmids TetO-FUW-Oct4, -
Sox2, -Klf4, -c-Myc or empty vector obtained from Addgene repository (www.addgene.com, 
plasmids 20323, 20326, 20322, 20324, and 12260, respectively). Confluent WT- and KO-MEFs 
were infected on day 1, and fed with tetracycline for the next two weeks.  Individual clones were 
counted, isolated, expanded by consecutive passage >4x, and aliquots were frozen.  Independent 
experiments were performed 3-5 times and averages used to calculate the reprogramming 
efficiency for all variations of the standard reprogramming methodology.  
Teratoma generation and assessment: Cells nearing confluency were lightly trypsinized (5% 
trypsin/1% EDTA) and washed twice in PBS.  Approximately 3.5 X 105 cells in 100ul were 
injected subcutaneously into the flanks of adult NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) 
mice. Mice were palpated for tumor growth and sacrificed when visible tumors were 1-2 cm 
across the longest diameter. Tumors were embedded, sectioned and stained with Hematoxylin 
and Eosin (H&E) at the core facility and analyzed by a trained pathologist at M.D. Anderson – 
Science Park Histology and Tissue Processing Facility Core located at The Virginia Harris 
Cockrell Cancer Research Center at The University of Texas MD Anderson Cancer Center, 
Science Park facility or at the University of Oklahoma Health Sciences Center. 
Chimera generation: Chimeras were generated in the Mouse Genetic Engineering Facility at 
the University of Texas at Austin. Pre-implantation embryos from C57BL/6-cBrd/cBrd/Cr 
(C57BL/6 albino) mice were injected at the 8-16 cell stage with either KO-iPS1 or KO-iPS2 cell 
lines. Chimeric embryos were transplanted into recipient mothers. Due to fostering issues, 
chimeric pups were harvest at E18.5 for analysis. Chimerism was determined by the presence of 
the Bright transgenic gene either by PCR amplification or X-gal staining. PCR of mouse tail 
DNA was performed using the following primers: KO F 5’- GTCTGCAGGTGCTTGAATGA-3’ 
R 5’- GCCTGAAGAACGAGATCAGC-3’; GAPDH F 5’- GTGGACCTGACCTGCCGTCT-3’ 
R 3’- GGAGGAGTGGGTGTCGCTGT-3’. X-gal staining of whole embryos was performed as 
previously described (Fire, 1992). 
Microarray: Cells were harvested by trypsin digestion. Total RNA was isolated (Qiagen 
RNeasy). On-column DNase digestion was performed (Qiagen) to remove genomic DNA 
contamination. RNA was reversed transcribed (Invitrogen). Labeling with cy3 random 
nonamers, array hybridizations, and data normalization were performed as described in the 
Nimblegen expression array protocol. Heatmaps were created using Java Treeview software 
(Saldanha, 2004).  GO analysis was performed using the DAVID online software (Huang et al., 
2008, 2009) 
qPCR Array: cDNA was generated from total mRNA isolated from WT- and KO-MEFs, ES 
cells and reprogrammed clones as indicated. qPCR array analyses were performed using the 
mouse embryonic stem cell RT2 Profiler™ PCR Array according to the manufacturer’s 
directions (SABiosciences PAMM-081A). Array results were analyzed using the online software 
provided by the manufacturer (http://www.sabiosciences.com/pcr/arrayanalysis.php). These data 
were normalized to Gapdh, and fold change was determined by comparing iPS values to those of 
WT-MEFs using GraphPad Prism® software. 
DNA Methylation Assay: Bisulfite analysis was conducted over a 175bp region, incorporating 9 
CpG sites, centered approximately 125bp upstream of the Oct4 transcription start site, as 
previously described (Fraenkel et al., 2007). 
qPCR: Total RNA was isolated using the Qiagen RNeasy kit, and cDNA was generated using 
Superscript III (Invitrogen). All qPCR assays were performed on an Applied Biosystems ViiA7 
thermocycler using SYBR green chemistry (Applied Biosystem SYBRGreen or Quanta 
BioSciences SYBR Green). qPCR primers were  as follows: Bright F 5’- 
GAGGTTATCAACAAGAAACTGT-3’ R 5’-GATACTTCATGTACTGTGTCCG-3’; GAPDH 
F 5’-TTCACCACCATGGAGAAGGC-3’R 5’-CCCTTTTGGCTCCACCCT-3’; Oct4 F 5′-
ACATCGCCAATCAGCTTGG-3′ R, 5′-AGAACCATACTCGAACCACATCC-3′; Sox2 F 5’-
ACAGATGCAACCGATGCACC -3’ R 5’-TGGAGTTGTACTGCAGGGCG-3’; Nanog F 5’-
TCTTCCTGGTCCCCACAGTTT -3’ R5’-GCAAGAATAGTTCTCGGGATGAA -3’; KLF4 F 
5’-GTAAGGTTTCTCGCCCTGTG-3’ R 5’-CAGGCTGTGGCAAAACCTAT-3’; REST F 5’-
ACCTGCAGCAAGTGCAACTA-3’ R 5’-GCGTTCTCCCTGTGTGAGTT-3’; Gata6 F 5’-
TCCTTCTACACAAGCGACCA-3’ R 5’-TCTCCCACTGCAGACATCAC-3’; Foxp2 F 5’-
ACATCGACAGCAATGGGAAC-3’ F 5’-CACGGGTTCTTCCTTGACAT-3’. Statistics were 
performed using Microsoft Excel. 
Chromatin immunoprecipitation (ChIP): MEF cells were first crosslinked with DTBP (Pierce) 
for 30 minutes, quenched with 100 mM Tris–HCl, pH 8.0, 150 mM NaCl, washed with PBS, 
then crosslinked with 1% formaldehyde for 30 minutes, and quenched with 125mM glycine for 
10 minutes. mES cells were crosslinked with formaldehyde only. Cells were then washed with 
PBS+PMSF and lysed in SDS lysis buffer (1% SDS, 10mM EDTA, and 50 mM Tris-Cl pH 8.1). 
Samples were sonicated using the Bioruptor (Diagenode) at medium speed for 20 minutes, 
diluted 1:5 with dilution buffer (0.1% SDS, 10% Triton-X, 0.5M EDTA, 1M Tris pH 8.1, 5M 
NaCl), and pre-cleared with Protein G Agarose beads at 4°C > 4 hours. 10 µg of α-BRIGHT 
rabbit polyclonal antibody was added overnight at 4°C. Samples were incubated with Protein G 
Agarose beads at 4°C > 4 hours and then washed twice in a low salt buffer (1% Deoxycholate, 
1% Triton X-100, 1mM EDTA, 50mM HEPES pH 7.5, 150mM NaCl), once in a high salt buffer 
(1% Deoxycholate, 1% Triton X-100, 1mM EDTA, 50mM HEPES pH 7.5, 500mM NaCl), once 
in a LiCl buffer (250mM LiCl, 0.5% NP-40, 0.5% Deoxycholate, 1mM EDTA, 10mM Tris pH 
8.1), and twice in TE. Samples were eluted at 65°C in elution buffer (1% SDS, 10mM EDTA, 
50mM Tris pH 8.1). Crosslinking was reversed overnight at 70°C. Samples were incubated in 
RNase A (15µg) at 37°C for 30 minutes, then in 40µg of glycogen and 120µg of proteinase K at 
37°C for 2 hours. DNA was Phenol/Chloroform extracted, ethanol precipitated, and resuspended 
in TE buffer. ChIP primers used were: Oct4 F 5’-AAAGTTTCTGTGGGGGACCT-3’, R 5’- 
AAAACCGGGAGACACAACTG-3’; Sox2 F 5’- TCATTTCAGGTGTAGAGTTGG-3’, R 5’- 
CCTATGTGTGAGCAAGAACTG-3’; Nanog (MEF ChIP) F 5’-
GTTGGAAACGTGGTGAACCT-3’, R 5’- GAAAACCGAGCAACAGAACC-3’; Negative 
control 5’- GGAGTCCCCTAGGAAGGCATTAATAGTTT-3’, R 5’- 
GGATTCTCTCGGCTTCAGACAGACTTT-3’. 
ChIP-Sequencing: ChIP was performed as described above. The NEB ChIP-seq library 
preparation kit (cat #: E6240) was used for ChIP-seq library generation following manufacturer’s 
instructions. ChIP DNA was sequenced using Illumina sequencing technology. Paired-sequence 
reads were ~2 X 50bp, and read numbers ranged from ~22-32M. Sequenced reads were mapped 
to the genome using the BWA aligner. Peak calling was performed using a Parzen window based 
algorithm.  Binding sites were visualized with a fixed step wiggle file in the UCSC genome 
browser.       
Electrophoretic mobility shift assay (EMSA):   In vitro translated BRIGHT was prepared per 
manufacturer’s instruction (Pierce).  Nuclear extracts were prepared by iso-osmotic/NP-40 lysis. 
Protein concentrations were quantified with Bradford reagents (Bio-Rad), and BRIGHT binding 
complexes were resolved on 4% nondenaturing acrylamide gels following incubation for 1 hour 
at 37°C with γ-32P-labeled probe as previously described (Nixon et al., 2004). The Nanog probe 
was a 120 bp AccI-SspI fragment positioned ~350bp upstream of the Nanog start site. The Oct4 
distal enhancer probe (DE, 289bp) and Bright binding probe (Bb, 353 bp) were PCR amplified 
from the Oct4 promoter region. The Sox2 probe was a MslI-ApaI fragment positioned ~3500bp 
upstream of the Sox2 start site. In some instances, antibodies were added after 20 minutes at RT 
and then incubated for 30 minutes on ice. α-BRIGHT rabbit polyclonal antibody was employed 
for supershifts. Cold competitions were performed using unlabeled probes as well as a previously 
established BRIGHT-binding site (a 150 bp BamHI–FokI fragment, IgVH) from the S107 V1 5′ 
flanking region (Webb et al., 1991). Competitors were pre-incubated in binding reaction at ~ 1X 
and 100X molar excess to labeled probes (~80,000 dpm per reaction). Complexes were identified 
by phosphoimaging. 
Immunoprecipitation (IP):  Cells were harvested, and lysates were pre-cleared with 100µl 
Protein G Agarose beads at 4°C > 4 hours. Lysates were incubated with 2µg of α-BRIGHT 
rabbit polyclonal antibody overnight at 4°C. Protein A Sepharose beads were incubated with the 
protein-antibody complex at 4°C > 4 hours, and beads were washed three times in TBS-T and 
once in TBS. 2X Sample buffer (125mM Tris pH 6.8, 2% SDS, 16% glycerol, 3% 2-
Mercaptoethanol, and Bromophenol blue) was added and the samples boiled for 5 minutes prior 
to resolution on SDS-PAGE. Blots were probed using the indicated primary antibodies as for 
western blots. 
Cell fractionation:  mES were grown in the presence (undifferentiated) or absence 
(differentiated) of LIF for 3 days. Cells were separated into cytoplasmic (Cy), soluble nuclear 
protein (NP), chromatin (CH), and nuclear matrix (NM) fractions as follows.  Approximately 
1x108 cells were washed twice in PBS and the pellet was resuspended in 2ml HNB buffer 
(500mM sucrose/15mM ris-HCL pH 7.5/60mM KCL/.25mM EDTA/.125mM EGTA/.5mM 
spermidine). Then 1ml HNBN buffer was added dropwise (HBN buffer+ 1% NP-40) and 
samples were incubated at 4°C for 5 minutes and centrifuged at 6,000g for 3 min at 4°C; the 
supernatant contained the Cy fraction. The pellet was resuspended in 1ml CSKT buffer (CSK 
buffer + 1% Triton-X), incubated at 4°C for 5 minutes before centrifugation at 3,000g for 3 min 
at 4°C; the supernatant contained the NP fraction.  The pellet was resuspended in 720µl CSK 
buffer (10mM Pipes pH 6.8/300mM sucrose/3mM MgCl2/2mM EGTA) and 30µl RNase-free 
DNase, incubated at 37°C for 15 minutes, then 250µl 1M AmSO4/CSK was added and incubated 
at 4°C for 5 minutes, before centrifugation at 3,000g for 3 min at 4°C; the supernatant included 
the CH fraction. The pellet was resuspended in 1ml 8M Urea, centrifuged at 13,000g for 5 
minutes, and the supernatant included the NM fraction. Equal amounts of protein for each 
fraction was determined by Bradford assay, separated on SDS-PAGE and probed with anti-
BRIGHT polyclonal antibody. 
Stable Bright overexpression:  Stable BRIGHT overexpressing mES cells were created using 
an in vivo biotinylation system as previously described (Kim et al., 2008). Briefly, BirA 
expressing mES were created by electroporating mES cells with the pEF1αBirAV5-neo vector 
and selecting cells with 300µg ml-1 G418. BRIGHT overexpressing cells were created by 
electroporating the pEF1αFLBIO-puro-Bright vector into BirA-mES and selecting stable clones 
using 1µg ml-1 puromycin. Overexpression within individual clones, estimated by western 
analysis with anti-BRIGHT, was ~3 to 4-fold above endogenous BRIGHT levels. 
Luciferase reporter assays:  DNA (~2µg) of the indicated luciferase vector, 0.7 µg Renilla 
luciferase, and ~3µg pCEM-Bright or pCME-EV (empty vector) were electroporated into ~5 X 
105 single cell suspensions of sub-confluent mES cells (Lonza, VPH-1001). Cells were seeded in 
6 well plates either under standard ES conditions (undifferentiated) or in the absence of either 
feeder cells or LIF (differentiated). Oct4 and Nanog luciferase constructs were obtained from 
Addgene repository (www.addgene.com):  Oct4-luciferase (Addgene plasmid 17221) (Takahashi 
et al., 2007), Nanog-luciferase (Addgene plasmid 16337)(Gu et al., 2005).  Sox2 luciferase 
constructs were a kind gift from Dr. Angel Martin, Fundación Inbiomed, San Sebastian, Spain. 
At least 2 independent experiments were performed in triplicate. Statistics were performed using 
Microsoft Excel. 
 Western blots: Cells were harvested using trypsin/EDTA and lysed in RIPA buffer containing 
1x protease inhibitors (Roche, 11-836-170-001) and PMSF (1mM).  Cells were briefly sonicated 
and centrifuged at >13,000g for 10 minutes at 4°C.  Protein concentrations of lysate were 
measured by Bradford assay (Bio-Rad), and ~ 40 ug total protein was resolved by 8% SDS-
PAGE. Blots were probed as indicated with anti-BRIGHT, anti-OCT4 (Santa Cruz sc-5279), 
anti-SOX2 (Santa Cruz sc-365964), anti-NANOG (Santa Cruz sc-374001), and anti-GAPDH 
(Santa Cruz sc-166545).  Signal was detected after secondary incubation with appropriate anti-
IgG by chemiluminescence using an ECL+ (GE) on a STORM phosphoimager. 
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